MedPath

Heliox delivered by high flow nasal cannula in infants with acute bronchiolitis

Completed
Conditions
Respiratory syncytial virus acute bronchiolitis
Respiratory
Respiratory syncytial virus acute bronchiolitis
Registration Number
ISRCTN99072045
Lead Sponsor
Mansoura University Children Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
80
Inclusion Criteria

1. Infants aged from 1 month to 2 years old
2. Patients who are admitted to the pediatric high dependency unit, with RSV acute bronchiolitis diagnosed clinically confirmed by laboratory testing
3. Display the diagnostic criteria of bronchiolitis including cough, tachypnea, chest retraction, prolonged expiratory time, sibilant rhonchi, and hyperinflation of the lungs
3. Cannot maintain oxygen saturation = 93% in room air and require supplemental oxygen on admission to hospital

Exclusion Criteria

1. No informed consent obtained
2. Require mechanical ventilation
3. Congenital heart defect that is haemodynamically significant (significant left-to-right shunting with or without pulmonary hypertension or right-to-left shunting)
4. Underlying chronic lung disease including bronchopulmonary dysplasia and previously diagnosed hyper-reactive airway diseases

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1. Partial arterial pressure and partial arterial oxygen are assessed using arterial blood samples at baseline, 2 hours and 24 hours<br>1.1. Oxygen saturation is assessed using pulse Masimo SET pulse oximeter continuously throughout the intervention<br>2. Respiratory distress is measured by the Modified Wood’s Clinical Asthma Score at 2 hours and 24 hours
Secondary Outcome Measures
NameTimeMethod
ength of hospital stay is measured by reviewing patient notes at the end of hospital stay.
© Copyright 2025. All Rights Reserved by MedPath